Piper Sandler Lowers Vicarious Surgical (NYSE:RBOT) Price Target to $10.50

Vicarious Surgical (NYSE:RBOT) had its price target cut by equities researchers at Piper Sandler from $12.00 to $10.50 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 12.42% from the stock’s current price.

Vicarious Surgical Trading Down 16.2 %

Shares of NYSE:RBOT traded down $1.80 during trading on Wednesday, hitting $9.34. 35,712 shares of the company were exchanged, compared to its average volume of 25,720. The stock has a 50 day moving average of $6.89 and a 200 day moving average of $7.63. Vicarious Surgical has a 52-week low of $4.27 and a 52-week high of $21.43.

Vicarious Surgical (NYSE:RBOT) last posted its earnings results on Monday, August 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.98) by $0.12. As a group, analysts expect that Vicarious Surgical will post -10.07 EPS for the current year.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.